Fidelity Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-32,463
Closed -$1.28M 5658
2023
Q2
$1.28M Sell
32,463
-389,150
-92% -$13.7M ﹤0.01% 2432
2023
Q1
$10.3M Sell
421,613
-53,911
-11% -$1.18M ﹤0.01% 1866
2022
Q4
$10.2M Sell
475,524
-97,968
-17% -$2.09M ﹤0.01% 1881
2022
Q3
$10.3M Buy
573,492
+110,809
+24% +$1.45M ﹤0.01% 1885
2022
Q2
$4.45M Buy
462,683
+433,512
+1,486% +$5.44M ﹤0.01% 2274
2022
Q1
$491K Buy
29,171
+19,185
+192% +$284K ﹤0.01% 2993
2021
Q4
$167K Buy
+9,986
New +$164K ﹤0.01% 2989
2019
Q2
Sell
-644
Closed -$1K 4294
2019
Q1
$1K Buy
+644
New +$901 ﹤0.01% 3537
2018
Q4
Sell
-1,000
Closed -$2K 4303
2018
Q3
$2K Buy
+1,000
New +$2.49K ﹤0.01% 3414
2016
Q4
Sell
-3,805,905
Closed -$176M 2730
2016
Q3
$176M Buy
3,805,905
+109,520
+3% +$6.18M 0.02% 735
2016
Q2
$189M Hold
3,696,385
0.03% 691
2016
Q1
$156M Sell
3,696,385
-1,458,850
-28% -$74.3M 0.02% 770
2015
Q4
$405M Buy
5,155,235
+354,763
+7% +$20.5M 0.05% 378
2015
Q3
$195M Sell
4,800,472
-325,600
-6% -$17.2M 0.03% 645
2015
Q2
$267M Hold
5,126,072
0.03% 549
2015
Q1
$239M Buy
5,126,072
+78,400
+2% +$4.07M 0.03% 611
2014
Q4
$226M Buy
5,047,672
+112,449
+2% +$4.72M 0.03% 619
2014
Q3
$192M Hold
4,935,223
0.03% 675
2014
Q2
$209M Buy
4,935,223
+1,861,972
+61% +$68.3M 0.03% 649
2014
Q1
$110M Buy
3,073,251
+1,194,488
+64% +$40.3M 0.02% 935
2013
Q4
$60.8M Buy
+1,878,763
New +$55.7M 0.01% 1215

Fidelity Investments's ISEE Position: Q3 2023 in Review

Fidelity Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 32,463 shares — an estimated $1.28M sold.

Fidelity Investments first reported a position in ISEE in Q4 2013 and held it in 21 quarters. The position peaked at $405M in Q4 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Fidelity Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Fidelity Investments sold 32,463 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.28M.
  • Fidelity Investments first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 21 quarters.
  • Fidelity Investments's IVERIC bio, Inc. Common Stock position peaked at $405M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Fidelity Investments's 13F filing for Q3 2023, filed 13 Nov 2023.